News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Cubist Pharmaceuticals, Inc. Announces Full Year 2009 Total Net Revenues of $562.1 Million
January 22, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the fourth quarter and year ended December 31, 2009.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Layoff Tracker
Biogen Upends 20 Employees After Axing AAV Work
September 30, 2025
·
207 min read
·
BioSpace Editorial Staff
Series A
Novo-Backed Crystalys Debuts With $205M to Tackle Gout
September 30, 2025
·
2 min read
·
Tristan Manalac
Editorial
GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling
September 29, 2025
·
1 min read
·
Annalee Armstrong
C-suite
GSK’s Emma Walmsley, Pharma’s First Woman CEO, Steps Down After 9 Years
September 29, 2025
·
4 min read
·
Annalee Armstrong